Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Addition of DLBS1033 to Standard Therapy for Acute Ischemic Stroke Patients

NCT02133521 is registered in ClinicalTrials.gov with Dexa Medica Group as lead sponsor.

NCT NCT02133521
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02133521 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Addition of DLBS1033 to Standard Therapy for Acute Ischemic Stroke Patients
Lead sponsor
Dexa Medica Group
Phase
Phase 2/3
Overall status
Terminated
Start date
November 11, 2014
Completion date
April 21, 2023
Enrollment
80 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke, lacunar anterior circulation infarct, partial anterior circulation infarct